Medicine and Dentistry
Lung Transplantation
96%
Surgery
71%
Non Small Cell Lung Cancer
69%
Lung
57%
Lung Cancer
52%
Clinical Stage
39%
Overall Survival
32%
Esophageal Cancer
31%
Surgeon
27%
Esophagectomy
26%
Lobectomy
23%
Pneumonectomy
22%
Malignant Neoplasm
21%
Odds Ratio
21%
Thorax Surgery
20%
Neoplasm
19%
Hazard Ratio
17%
Lymph Node
16%
Transplantation
16%
Health Care Cost
15%
Radiation Therapy
13%
Stereotactic Body Radiation Therapy
13%
Computer Assisted Tomography
13%
Video-Assisted Thoracoscopic Surgery
12%
Disease
12%
Primary Graft Dysfunction
12%
Cost-Effectiveness Analysis
12%
Chemoradiotherapy
10%
Comorbidity
10%
Allograft
10%
Adjuvant Chemotherapy
10%
Logistic Regression Analysis
8%
Cancer Surgery
8%
Organ Donor
8%
Clinical Trial
8%
Acute Graft Rejection
7%
Heart Transplantation
7%
Proportional Hazards Model
7%
Chemotherapy
6%
COVID-19
6%
Lung Cancer Screening
6%
Donor Management
6%
Adjuvant Therapy
6%
Prevalence
6%
Organ Transplantation
6%
Patient-Reported Outcome
6%
Thoracic Cancer
6%
Endobronchial Ultrasonography
6%
Hernioplasty
6%
Recurrent Disease
5%
Keyphrases
Lung Transplantation
100%
Non-small Cell Lung Cancer (NSCLC)
53%
Stage I Lung Cancer
36%
Lung Cancer
33%
Confidence Interval
32%
Esophageal Cancer
30%
Lung
29%
Overall Survival
24%
Resection
22%
Esophagectomy
22%
Clinical Stage I
21%
Transplantation
18%
National Cancer Database
18%
Primary Graft Dysfunction
17%
Odds Ratio
16%
Hazard Ratio
16%
Early-stage Lung Cancer
16%
Pathologic
15%
Surgical Treatment
15%
Surgical Resection
14%
Improved Survival
14%
Thoracic Surgery
13%
Lobectomy
13%
Donor Lung
13%
Adjuvant Chemotherapy
11%
Induction Therapy
11%
Stereotactic Body Radiation Therapy
11%
Surgeons
10%
Computed Tomography
10%
Video-assisted Thoracoscopic Surgery
9%
Clinical Outcomes
9%
30-day Mortality
8%
Healthcare Facilities
8%
Size Matching
8%
Donor Care
8%
Society of Thoracic Surgeons
8%
Allocation Policy
8%
Lung Donor
8%
Pathological Stage
8%
Pulmonary Resection
8%
Cost-effectiveness Analysis
8%
Node-positive
8%
Post-esophagectomy
7%
VATS Lobectomy
7%
5-year Survival
7%
Tumor
7%
Clinical High Risk
7%
Lung Allocation
7%
Surgical Outcomes
7%
Lung Resection
7%
